(WRB) W. R. Berkley - Ratings and Ratios
Commercial Insurance, Reinsurance, Excess, Specialty, Casualty
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.6% |
| Value at Risk 5%th | 32.9% |
| Relative Tail Risk | -3.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.15 |
| Alpha | 25.97 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.469 |
| Beta | 0.253 |
| Beta Downside | 0.192 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.29% |
| Mean DD | 7.82% |
| Median DD | 5.71% |
Description: WRB W. R. Berkley October 14, 2025
W. R. Berkley Corp. (NYSE: WRB) is a U.S.–based insurance holding company that writes commercial lines worldwide through two primary segments: Insurance, and Reinsurance & Monoline Excess.
The **Insurance** segment underwrites a broad mix of commercial coverages-including excess and surplus lines, admitted lines, specialty personal lines, and niche products such as fine-arts, cyber-risk, and life-sciences insurance. It also offers accident-and-health, workers’ compensation, and various liability policies (e.g., D&O, professional liability, EPLI) to small- and medium-sized insureds, plus a suite of personal-lines products (home, auto, collector-vehicle). The segment additionally provides at-risk and alternative-risk program management services and writes business for the Lloyd’s market.
The **Reinsurance & Monoline Excess** segment delivers treaty and facultative reinsurance across property-and-casualty lines, including automatic, semi-automatic, and individual-risk arrangements. It also markets turnkey solutions for cyber, employment-practices liability, liquor-liability, and violent-event exposures.
Key financial metrics (as of FY 2023) show a **combined ratio of 92.5%**, indicating underwriting profitability, and a **return on equity (ROE) of 14.2%**, well above the industry median of ~9%. The company’s **risk-based capital (RBC) ratio stood at 300%**, reflecting a strong capital buffer amid a hardening reinsurance market. These figures suggest WRB is positioned to capture upside from rising premium volumes while maintaining disciplined risk management.
Macro-level drivers that materially affect WRB’s outlook include: (1) **interest-rate environments**, which influence investment income that historically accounts for ~30% of total earnings for property-and-casualty carriers; (2) **commercial insurance demand** tied to U.S. business-investment cycles and the ongoing expansion of technology-heavy sectors that require specialized cyber and professional-liability coverages; and (3) **climate-related loss trends**, which are reshaping pricing and capacity in property reinsurance and could elevate the value of WRB’s reinsurance-excess capabilities.
From a sector perspective, the **hardening cycle in property-and-casualty reinsurance**-driven by constrained capacity and elevated loss reserves-has been pushing ceding insurers to seek excess and monoline solutions, a niche where WRB’s Reinsurance & Monoline segment is well-aligned.
For analysts looking to deepen their quantitative assessment, a useful next step is to compare WRB’s **price-to-book (P/B) ratio** and **embedded value** against peers such as Chubb (CB) and Alleghany (Y) to gauge relative market pricing and hidden upside.
**If you want a data-rich, model-ready view of WRB’s valuation dynamics, ValueRay’s platform offers granular financials and scenario analytics that can help you test these hypotheses further.**
WRB Stock Overview
| Market Cap in USD | 29,262m |
| Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 1984-09-07 |
| Return 12m vs S&P 500 | 14.1% |
| Analyst Rating | 3.56 of 5 |
WRB Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.72% |
| Yield on Cost 5y | 5.14% |
| Yield CAGR 5y | 36.67% |
| Payout Consistency | 88.2% |
| Payout Ratio | 31.2% |
WRB Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 18.85% |
| CAGR/Max DD Calmar Ratio | 0.72 |
| CAGR/Mean DD Pain Ratio | 2.41 |
| Current Volume | 2008.7k |
| Average Volume | 2309.8k |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.91b TTM) > 0 and > 6% of Revenue (6% = 879.2m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -0.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.07% (prev 240.5%; Δ -226.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.40b > Net Income 1.91b (YES >=105%, WARN >=100%) |
| Net Debt (-2.40b) to EBITDA (2.53b) ratio: -0.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (400.2m) change vs 12m ago -0.40% (target <= -2.0% for YES) |
| Gross Margin 20.98% (prev 22.72%; Δ -1.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 34.86% (prev 32.69%; Δ 2.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.83 (EBITDA TTM 2.53b / Interest Expense TTM 127.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.31
| (A) 0.05 = (Total Current Assets 2.73b - Total Current Liabilities 668.7m) / Total Assets 43.72b |
| (B) 0.30 = Retained Earnings (Balance) 13.31b / Total Assets 43.72b |
| (C) 0.04 = EBIT TTM 1.88b / Avg Total Assets 42.04b |
| (D) 0.68 = Book Value of Equity 22.98b / Total Liabilities 33.91b |
| Total Rating: 2.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.77
| 1. Piotroski 6.0pt |
| 2. FCF Yield 11.21% |
| 3. FCF Margin 22.72% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda -0.95 |
| 6. ROIC - WACC (= 6.05)% |
| 7. RoE 20.94% |
| 8. Rev. Trend 96.88% |
| 9. EPS Trend -28.91% |
What is the price of WRB shares?
Over the past week, the price has changed by +1.43%, over one month by +4.13%, over three months by +7.84% and over the past year by +28.24%.
Is WRB a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the WRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.9 | -5.4% |
| Analysts Target Price | 73.9 | -5.4% |
| ValueRay Target Price | 94.8 | 21.4% |
WRB Fundamental Data Overview November 17, 2025
P/E Trailing = 16.1765
P/E Forward = 16.2075
P/S = 1.9968
P/B = 2.9862
P/EG = 11.5789
Beta = 0.381
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -2.40b USD (from netDebt column, last quarter)
Enterprise Value = 29.70b USD (29.26b + Debt 2.84b - CCE 2.40b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
FCF Yield = 11.21% (FCF TTM 3.33b / Enterprise Value 29.70b)
FCF Margin = 22.72% (FCF TTM 3.33b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.68 (Enterprise Value 29.70b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 4.08 (Total Current Assets 2.73b / Total Current Liabilities 668.7m)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.80b)
Debt / EBITDA = -0.95 (Net Debt -2.40b / EBITDA 2.53b)
Debt / FCF = -0.72 (Net Debt -2.40b / FCF TTM 3.33b)
Total Stockholder Equity = 9.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 1.91b / Total Assets 43.72b)
RoE = 20.94% (Net Income TTM 1.91b / Total Stockholder Equity 9.10b)
RoCE = 15.78% (EBIT 1.88b / Capital Employed (Equity 9.10b + L.T.Debt 2.84b))
RoIC = 12.46% (NOPAT 1.49b / Invested Capital 11.94b)
WACC = 6.41% (E(29.26b)/V(32.10b) * Re(6.95%) + D(2.84b)/V(32.10b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 6.95% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 80.04% ; FCFE base≈3.38b ; Y1≈3.85b ; Y5≈5.27b
Fair Price DCF = 240.1 (DCF Value 91.23b / Shares Outstanding 380.0m; 5y FCF grow 15.94% → 3.0% )
EPS Correlation: -28.91 | EPS CAGR: -1.91% | SUE: 0.63 | # QB: 0
Revenue Correlation: 96.88 | Revenue CAGR: 8.46% | SUE: 0.83 | # QB: 0
Additional Sources for WRB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle